Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Roque

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Transboundary and Emerging Diseases|September 23, 2020
Zoonotic parasites infecting free-living armadillos from BrazilDanilo Kluyber, Arnaud L J Desbiez, Nina Attias, et al.
Gynecologic Oncology|December 14, 2023
Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trialsMichael T Richardson, Danika Barry, Jecca R Steinberg, et al.
ESMO Gastrointestinal Oncology|May 22, 2026
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort studyH Vandeputte, A Casadei-Gardini, F Peeters, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Transboundary and Emerging Diseases|September 23, 2020
Zoonotic parasites infecting free-living armadillos from BrazilDanilo Kluyber, Arnaud L J Desbiez, Nina Attias, et al.
Gynecologic Oncology|December 14, 2023
Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trialsMichael T Richardson, Danika Barry, Jecca R Steinberg, et al.
ESMO Gastrointestinal Oncology|May 22, 2026
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort studyH Vandeputte, A Casadei-Gardini, F Peeters, et al.
Pageof 11